<DOC>
	<DOCNO>NCT02190019</DOCNO>
	<brief_summary>Mild cognitive impairment ( MCI ) precursor dementia . Apathy , profound loss motivation , common behavioral problem MCI . Presence apathy may increase chance MCI patient convert Alzheimer 's Dementia . Repetitive Transcranial Magnetic Stimulation ( rTMS ) , non-invasive tool , recently approve treatment refractory depression . Since dysfunction frontal lobe brain see patient apathy , rTMS frontal lobe might helpful treat . Study hypotheses include rTMS dorsolateral prefrontal cortex ( DLPFC ) improve apathy executive function well sham treatment MCI</brief_summary>
	<brief_title>Transcranial Magnetic Stimulation Apathy Mild Cognitive Impairment : Pilot Study</brief_title>
	<detailed_description>Objective : Mild cognitive impairment ( MCI ) precursor dementia . Apathy , profound loss motivation , common behavioral problem MCI . Presence apathy may increase chance MCI patient convert Alzheimer 's Dementia . Repetitive Transcranial Magnetic Stimulation ( rTMS ) , non-invasive tool , recently approve treatment refractory depression . Since dysfunction frontal lobe brain see patient apathy , rTMS frontal lobe might helpful treat . Specific Aims : - To determine efficacy rTMS dorsolateral prefrontal cortex ( DLPFC ) treat apathy MCI comparison sham treatment . - To compare efficacy rTMS DLPFC executive function MCI comparison sham treatment . Research Plan : Current study randomize sham control cross-over study daily rTMS . Methods : 20 subject MCI apathy enrol randomize 8 total 20 session treatment ( 2 week sham , 2 week rTMS , 4 week washout period ) . Subjects randomly assign rTMS sham treatment consent . After 2 week treatment 4 week period treatment . At end 4-week wash period , subject cross next treatment arm ( i.e . receive rTMS begin receive sham treatment vice versa ) . Subjects follow four additional week treatment . Apathy assess use Apathy Evaluation Scale . Memory , executive function , functional status caregiver burden assess .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>1 . Subjects age ≥ 55 year , 2 . Subjects meet Petersen 's criterion MCI , 3 . Apathy Evaluation ScaleClinician ( AESC ) score ≥ 30 , 4 . Mini Mentla Status Examination ( MMSE ) ≥ 23 , 5 . Subjects clear TMS adult safety scale ( TASS ) 6 . On stable dose antidepressant ( applicable ) least two month 1 . Subjects take medication know increase risk seizure 2012 Beers criterion : Bupropion , chlorpromazine , clozapine , maprotiline , olanzapine , thioridazine , thiothixene , tramadol . 2 . Subjects take medication know increase seizure threshold list Beers criterion opinion PI increase seizure threshold : tricyclic antidepressant , theophylline , methylphenidate , highdose thyroid supplementation . 3 . Subjects take ototoxic medication : Aminoglycosides , Cisplatin . 4 . Subjects current episode major depression 5 . History bipolar disorder 6 . Subjects history seizure first degree relative seizure disorder 7 . Subjects implanted device : wearable implantable cardioverter defibrillator , conductive , ferromagnetic , magnetic sensitive metal implant nonremovable within 30 cm treatment coil cochlear implant 8 . Subjects diagnosis current alcohol relate problem 9 . Subjects history stroke , aneurysm , cranial neurosurgery 10 . Any condition opinion study physician likely compromise ability safely participate study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>91 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>apathy</keyword>
	<keyword>executive function</keyword>
</DOC>